Q3 2015

Filed Nov 12, 2015 · 10-Q · 43 days after period end · 0001121781-15-000315

Q3 2015 · 10-Q

Revenue

$8.00K

−63.6% vs Q3 2014

Net Income

-$2.19M

N/M vs Q3 2014

EPS Diluted

-$1.75

N/M vs Q3 2014

Gross Profit-$136,000N/M

Operating Income

Same quarter

Metric	Q3 2015	Q3 2014	Q3 2013	Q3 2012
Revenue	$8.00K	$22.00K	$86.00K	$693.00K
Net Income	-$2.19M	-$2.97M	-$1.44M	-$986.00K
EPS Diluted	-$1.75	-$0.04	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR